Johnson & Johnson has warned its customers about a security vulnerability in one of its insulin pumps. If the flaw in the Animas OneTouch Ping insulin pump was exploited, it could allow an attacker to deliver a potentially fatal overdose of insulin. The warnings were mailed to 114,000 customers throughout the United States and Canada, as well as doctors who might prescribe the device. It is believed that it is the first time a pharmaceutical company has warned its customers about a security vulnerability. Johnson & Johnson were eager to emphasize that the chance of someone executing the vulnerability is “extremely low.”…

This story continues at The Next Web